BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29717376)

  • 1. Development and validation of an HPLC-MS/MS method for the determination of arginine-vasopressin receptor blocker conivaptan in human plasma and rat liver microsomes: application to a metabolic stability study.
    Alrabiah H; Kadi AA; Attwa MW; Mostafa GAE
    Chem Cent J; 2018 May; 12(1):47. PubMed ID: 29717376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validated LC-MS/MS Method for the Quantification of Ponatinib in Plasma: Application to Metabolic Stability.
    Kadi AA; Darwish HW; Attwa MW; Amer SM
    PLoS One; 2016; 11(10):e0164967. PubMed ID: 27764191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid chromatography tandem mass spectrometry method for the quantification of vandetanib in human plasma and rat liver microsomes matrices: metabolic stability investigation.
    Amer SM; Kadi AA; Darwish HW; Attwa MW
    Chem Cent J; 2017 May; 11(1):45. PubMed ID: 29086823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LC-MS/MS method for the quantification of masitinib in RLMs matrix and rat urine: application to metabolic stability and excretion rate.
    Amer SM; Kadi AA; Darwish HW; Attwa MW
    Chem Cent J; 2017 Dec; 11(1):136. PubMed ID: 29274040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A reliable and stable method for the determination of foretinib in human plasma by LC-MS/MS: Application to metabolic stability investigation and excretion rate.
    Attwa MW; Kadi AA; Darwish HW; Amer SM; Alrabiah H
    Eur J Mass Spectrom (Chichester); 2018 Aug; 24(4):344-351. PubMed ID: 29629565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A highly efficient and sensitive LC-MS/MS method for the determination of afatinib in human plasma: application to a metabolic stability study.
    Kadi AA; Abdelhameed AS; Darwish HW; Attwa MW; Al-Shakliah NS
    Biomed Chromatogr; 2016 Aug; 30(8):1248-55. PubMed ID: 26683307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of HPLC-MS/MS method for the determination of lixivaptan in mouse plasma and its application in a pharmacokinetic study.
    Kadi AA; Alrabiah H; Attwa MW; Attia S; Mostafa GAE
    Biomed Chromatogr; 2017 Nov; 31(11):. PubMed ID: 28493402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a UPLC-MS/MS method for determination of motesanib in plasma: Application to metabolic stability and pharmacokinetic studies in rats.
    Ezzeldin E; Iqbal M; Al-Salahi R; El-Nahhas T
    J Pharm Biomed Anal; 2019 Mar; 166():244-251. PubMed ID: 30665192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous determination of atorvastatin, metformin and glimepiride in human plasma by LC-MS/MS and its application to a human pharmacokinetic study.
    Polagani SR; Pilli NR; Gajula R; Gandu V
    J Pharm Anal; 2013 Feb; 3(1):9-19. PubMed ID: 29403791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A validated HPLC-ESI-MS/MS method for quantification of 2-hydroxy-4-methoxy benzoic acid from rat plasma and its application to pharmacokinetic study using sparse sampling methodology.
    Nair SN; Mhatre M; Menon S; Shailajan S
    J Pharm Biomed Anal; 2014 Nov; 100():190-198. PubMed ID: 25168218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of LC-MS/MS method for simultaneous determination of sofosbuvir and daclatasvir in human Plasma: Application to pharmacokinetic study.
    Abdallah OM; Abdel-Megied AM; Gouda AS
    Biomed Chromatogr; 2018 Jun; 32(6):e4186. PubMed ID: 29314090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous quantitative determination of seven novel tyrosine kinase inhibitors in plasma by a validated UPLC-MS/MS method and its application to human microsomal metabolic stability study.
    Ezzeldin E; Iqbal M; Herqash RN; ElNahhas T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Jan; 1136():121851. PubMed ID: 31812004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPLC-APCI-MS/MS method for the determination of catalpol in rat plasma and cerebrospinal fluid: application to an in vivo pharmacokinetic study.
    Wang Q; Xing M; Chen W; Zhang J; Qi H; Xu X
    J Pharm Biomed Anal; 2012 Nov; 70():337-43. PubMed ID: 22677654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of cefadroxil in rat plasma and urine using LC-MS/MS and its application to pharmacokinetic and urinary excretion studies.
    Jin HE; Kim IB; Kim YC; Cho KH; Maeng HJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Feb; 947-948():103-10. PubMed ID: 24412692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination and pharmacokinetics study of oxyclozanide suspension in cattle by LC-MS/MS.
    Zhang J; Bai Y; Li B; Zhou X; Si H; Zhang J
    BMC Vet Res; 2019 Jun; 15(1):210. PubMed ID: 31234851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous determination of sibutramine and its active metabolites in human plasma by LC-MS/MS and its application to a pharmacokinetic study.
    Bae JW; Choi CI; Jang CG; Lee SY
    Biomed Chromatogr; 2011 Nov; 25(11):1181-8. PubMed ID: 21294141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a HPLC-MS/MS method for the determination of phytolaccagenin in rat plasma and application to a pharmacokinetic study.
    Wei F; Singh RS; Fueth M; Swarts S; Okunieff P; Derendorf H
    J Pharm Biomed Anal; 2015 Mar; 107():82-8. PubMed ID: 25575173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous determination of telmisartan and amlodipine in human plasma by LC-MS/MS and its application in a human pharmacokinetic study.
    Ravi VB; Inamadugu JK; Pilli NR; Sreenivasulu V; Ponneri V
    J Pharm Anal; 2012 Oct; 2(5):319-326. PubMed ID: 29403761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous determination of methotrexate, dasatinib and its active metabolite N- deshydroxyethyl dasatinib in rat plasma by LC-MS/MS: method validation and application to pharmacokinetic study.
    Thappali SR; Varanasi KV; Veeraraghavan S; Vakkalanka SK; Khagga M
    Arzneimittelforschung; 2012 Dec; 62(12):624-30. PubMed ID: 23138519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of an LC-MS/MS method for quantitative determination of GS87, a novel antineoplastic agent, in mouse plasma.
    Kunati SR; Yang S; Wald D; Xu Y
    J Pharm Biomed Anal; 2018 May; 153():145-151. PubMed ID: 29482106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.